Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes

Overview of attention for article published in Clinical Genitourinary Cancer, October 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 1 X post from an account with 38 followers.

Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes https://t.co/xEmlvKM4Sk

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.